Barrett & Company’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.6K Buy
423
+42
+11% +$3.12K 0.01% 357
2025
Q4
$30.2K Sell
381
-17
-4% -$1.3K 0.01% 350
2025
Q3
$29.1K Hold
398
0.01% 359
2025
Q2
$30.2K Buy
398
+268
+206% +$19K 0.01% 361
2025
Q1
$9.88K Hold
130
﹤0.01% 443
2024
Q4
$8.59K Hold
130
﹤0.01% 442
2024
Q3
$9.06K Hold
130
﹤0.01% 434
2024
Q2
$6.87K Buy
+130
New +$7.89K ﹤0.01% 462

Other funds holding SOLV

Barrett & Company's SOLV Position: Q1 2026 in Review

Barrett & Company increased its Solventum (SOLV) stake by 11% in Q1 2026, buying an estimated $3.12K and bringing the position to 423 shares worth $27.6K. The position accounts for 0.01% of the portfolio, ranked #357.

Barrett & Company first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $30.2K in Q4 2025. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Barrett & Company held 423 shares of Solventum worth $27.6K as of Q1 2026.
  • Barrett & Company bought 42 Solventum shares in Q1 2026, an estimated $3.12K.
  • Solventum made up 0.01% of Barrett & Company's portfolio in Q1 2026, its #357 holding.
  • Barrett & Company first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • Barrett & Company's Solventum position peaked at $30.2K in Q4 2025.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.